Diagnostic and Interventional Cardiology

Cardiovascular Consultants, Ltd. in Phoenix brings state-of-the-art cardiac imaging to its statewide network of Arizona practices

Phoenix Cardiology Practice Installs the First and Fastest Cardiovascular CT Scanner in the State, Arineta’s SpotLight Duo

July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

July 16, 2024

Ultrahuman’s App Store ‘PowerPlugs’ launches with the Atrial Fibrillation (AFib) PowerPlug. The Ultrahuman Ring AIR is the first smart ring in the world to detect AFib

News | Wearables

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

July 16, 2024 — Ultrahuman, a pioneer in wearable technology, launches PowerPlugs, a platform for individual apps and ...

July 16, 2024

A strategic deal to deliver virtual value-based cardiology care to health systems has been announced by the executive team at Guidehealth, a provider of AI-enabled healthcare services and Story Health, a digital company involved in specialty care delivery.

News | Cardiovascular Business

Strategic Deal to Deliver Virtual Value-based Cardiology Care Announced by Guidehealth and Story Health

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

July 15, 2024

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Data show that applying AI to VCG data provides more consistent and reliable detection of atrial flutter

News | Wearables

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

July 15, 2024 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of ...

July 15, 2024

Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd.

News | Cardiovascular Business

Edwards Lifesciences to Acquire Innovalve

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

July 15, 2024

News | Cardiac Imaging

Artificial Intelligence Speeds Up Heart Scans, Leading to Efficiency and Improving Outcomes

July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of ...

July 12, 2024

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

First implant of Amvia Sky in Canada performed at the Centre Hospitalier de l'Université de Montréal

News | Implantable Cardiac Monitor (ICM)

Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP

July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...

July 11, 2024

Further expands HeartSciences extensive patent portfolio

News | Artificial Intelligence

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...

July 11, 2024

Medical device company R3 Vascular Inc., a developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.

News | Cardiovascular Business

R3 Vascular Appoints Josh Smale as Vice President of Global Clinical and Scientific Affairs

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

July 11, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM).

News | ACC

Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups

July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...

July 10, 2024

Feature | Remote Monitoring | By Stuart Long

Step Into the Cardiology Clinic of the Future: Bringing Virtual Cardiac Care Delivery and Virtual Telemetry to Life in Your Practice’s Clinical Workflows

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular ...

July 10, 2024

News | Cardiovascular Clinical Studies

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

July 10, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)

News | Pharmaceuticals

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

July 10, 2024

Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.

News | AHA

American Heart Association Announces New 2024-2025 National Volunteer Leaders

July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...

July 09, 2024

Counties tend to be more rural and socioeconomically disadvantaged

News | Cardiovascular Business

Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

July 09, 2024